Dose-Dense Doxorubicin and Cyclophosphamide Followed by Weekly Paclitaxel With Trastuzumab and Lapatinib in HER2/neu–Overexpressed/Amplified Breast Cancer Is Not Feasible Because of Excessive Diarrhea
CHAN DANG, LIN, Nancy, NORTON, Larry, WINER, Eric, HUDIS, Clifford, MOY, Beverly, COME, Steven, SUGARMAN, Steven, MORRIS, Patrick, ABBRUZZI, Alyson, CHEN, Carol, STEINGART, Richard, PATIL, Sujata
Published in Journal of clinical oncology (20.06.2010)
Published in Journal of clinical oncology (20.06.2010)
Get full text
Journal Article
Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib
MORRIS, Patrick G, CHEN, Carol, PATIL, Sujata, DICKLER, Maura, MCARTHUR, Heather L, WINER, Eric, NORTON, Larry, HUDIS, Clifford A, DANG, Chau T, STEINGART, Richard, FLEISHER, Martin, LIN, Nancy, MOY, Beverly, COME, Steven, SUGARMAN, Steven, ABBRUZZI, Alyson, LEHMAN, Robert
Published in Clinical cancer research (15.05.2011)
Published in Clinical cancer research (15.05.2011)
Get full text
Journal Article
Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer
Gucalp, Ayca, Sparano, Joseph A, Caravelli, James, Santamauro, Jean, Patil, Sujata, Abbruzzi, Alyson, Pellegrino, Christine, Bromberg, Jackie, Dang, Chau, Theodoulou, Maria, Massague, Joan, Norton, Larry, Hudis, Clifford, Traina, Tiffany A
Published in Clinical breast cancer (01.10.2011)
Published in Clinical breast cancer (01.10.2011)
Get full text
Journal Article
Long‐term cardiac safety and outcomes of dose‐dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer
Morris, Patrick G., Iyengar, Neil M., Patil, Sujata, Chen, Carol, Abbruzzi, Alyson, Lehman, Robert, Steingart, Richard, Oeffinger, Kevin C., Lin, Nancy, Moy, Beverley, Come, Steven E., Winer, Eric P., Norton, Larry, Hudis, Clifford A., Dang, Chau T.
Published in Cancer (15.11.2013)
Published in Cancer (15.11.2013)
Get full text
Journal Article
Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)
Iyengar, Neil M., Morris, Patrick Glyn, Patil, Sujata, Chen, Carol, Abbruzzi, Alyson, Lehman, Robert James, Steingart, Richard, Oeffinger, Kevin C., Lin, Nancy U., Moy, Beverly, Come, Steven E., Winer, Eric P., Norton, Larry, Hudis, Clifford, Dang, Chau T.
Published in Journal of clinical oncology (10.09.2013)
Published in Journal of clinical oncology (10.09.2013)
Get full text
Journal Article
Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)
Morris, Patrick Glyn, Iyengar, Neil M., Patil, Sujata, Chen, Carol, Abbruzzi, Alyson, Lehman, Robert James, Steingart, Richard, Oeffinger, Kevin C., Lin, Nancy, Moy, Beverly, Come, Steven E., Winer, Eric P., Norton, Larry, Hudis, Clifford, Dang, Chau T.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article